Chancellor Rachel Reeves Intends Specific Action on Living Costs in Upcoming Financial Plan

Chancellor Reeves has announced she is preparing "targeted action to deal with cost of living challenges" in next month's Budget.

In comments to the BBC, she stated that curbing price rises is a shared task of both the administration and the Bank of England.

The United Kingdom's inflation rate is forecast to be the most elevated among the G7 advanced economies this year and next.

Possible Utility Cost Measures

Reports indicate the administration could intervene to reduce energy bills, for example by slashing the current 5% level of VAT applied on energy supplies.

An additional approach is to reduce some of the regulatory levies currently added to bills.

Fiscal Limitations and Analyst Predictions

The administration will receive the next draft from the official forecaster, the OBR, on Monday, which will clarify how much scope there is for such actions.

The view from the majority of analysts is that the Chancellor will have to introduce higher taxes or budget cuts in order to adhere to her voluntary borrowing rules.

Previously on Thursday, calculations indicated there was a £22bn shortfall for the chancellor to resolve, which is at the more modest range of projections.

"It is a joint responsibility between the Bank of England and the government to continue tackling some of the drivers of inflation," Reeves stated to reporters in Washington, at the conferences of the International Monetary Fund and global financial institution.

Revenue Commitments and Global Issues

While much of the focus has been on probable tax increases, the chancellor said the most recent figures from the OBR had not altered her commitment to campaign commitments not to increase tax levels on earnings tax, sales tax or social security contributions.

She blamed an "uncertain world" with growing geopolitical and commercial concerns for the Budget tax moves, likely to be directed on those "most able to pay."

Global Trade Tensions

Addressing apprehensions about the United Kingdom's economic relations with the Asian nation she said: "Our security interests invariably come first."

Last week's statement by Chinese authorities to tighten export controls on rare earths and other materials that are key for advanced tech production led US President Donald Trump to threaten an additional 100% import tax on imports from the Asian country, raising the prospect of an all-out trade war between the two largest economies.

The US Treasury Secretary described the Chinese decision "economic coercion" and "a global supply chain power grab."

Questioned on accepting the US offer to join its battle with China, Reeves said she was "deeply worried" by Chinese actions and urged the Beijing authorities "to avoid restrictions and restrict access."

She said the move was "bad for the world economy and creates additional obstacles."

"It is my opinion there are sectors where we should address Chinese policies, but there are also valuable prospects to export to China's economy, including banking sector and other areas of the economy. We've got to maintain that equilibrium right."

The Treasury chief also confirmed she was collaborating with other major economies "on our own essential resources plan, so that we are more independent."

NHS Drug Costs and Investment

The Chancellor also acknowledged that the price the NHS spends on drugs could go up as a result of current negotiations with the US government and its pharmaceutical firms, in exchange for lower tariffs and capital.

Some of the world's largest pharmaceutical manufacturers have said recently that they are either halting or scrapping operations in the United Kingdom, with several attributing the low prices they are getting.

Recently, the Science Minister said the price the health service spends on medicines would need to increase to stop companies and pharmaceutical investment departing from the UK.

Reeves told media: "It has been observed as a result of the payment system, that clinical trials, innovative medicines have not been offered in the United Kingdom in the way that they are in other European countries."

"We want to make sure that people receiving treatment from the National Health Service are can receive the top essential drugs in the globe. And so we are looking at these issues, and... aiming to attract increased capital into Britain."